APSGX | PMAQX | APSGX / PMAQX | |
Total Expense Ratio | 0.85 | 0.59 | 144% |
Annual Report Gross Expense Ratio | 0.98 | 0.59 | 166% |
Fund Existence | 13 years | 9 years | - |
Gain YTD | -3.636 | 6.520 | -56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 346M | 32.3B | 1% |
Annual Yield % from dividends | 0.00 | 0.19 | - |
Returns for 1 year | -4.97 | 11.45 | -43% |
Returns for 3 years | 3.14 | 52.26 | 6% |
Returns for 5 years | -7.18 | 56.61 | -13% |
Returns for 10 years | -6.49 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSLIX | 16.78 | N/A | N/A |
Goldman Sachs Large Cap Value Instl | |||
JSVRX | 27.67 | N/A | N/A |
JPMorgan Small Cap Value R5 | |||
DRESX | 23.87 | N/A | N/A |
Driehaus Emerging Markets Small Cap Gr | |||
CGFEX | 79.82 | -0.33 | -0.41% |
American Funds Growth Fund of Amer 529E | |||
JAGLX | 65.55 | -1.12 | -1.68% |
Janus Henderson Global Life Sciences T |